About

ANSHI’S MISSION

At Anshi Pharmaceutical, our mission is to lead the way in developing cutting-edge compounds to address some of the most pressing healthcare challenges of our time—non-alcoholic steatohepatitis (NASH), obesity, and osteoporosis. We recognize that these conditions affect millions of lives worldwide, and we are driven by a steadfast commitment to bring transformative solutions to patients in need.

We envision a future where NASH, obesity, and osteoporosis are no longer insurmountable health concerns. Instead, they are met with innovative treatments that offer renewed hope, improved well-being, and a better quality of life for patients. Our unwavering dedication to scientific excellence and patient-centric values fuels our quest to redefine healthcare standards and make a tangible impact on global health.

To lead the way in developing cutting-edge compounds to address non-alcoholic steatohepatitis (NASH)

APPROACH

Experienced Leadership

We foster an environment that inspires colleagues to expand their horizons and strive to achieve what was thought to be impossible. Led by our Chief Executive Office, Ryan Chen, our teams of seasoned professionals apply their extensive experience to enable the development of new medicines. We work across traditional disciplines to answer difficult scientific, regulatory, and business questions.

Clinical Development

Scientific Research

Purposeful Collaboration

MEET OUR TEAM

Anshi brings world-class experience at multinational pharmaceutical companies that ensures success for the company’s visionary approach to drug development and commercialization. With a strong track record of successfully introducing major drugs into US and China markets, our team understands the regulatory and market requirements.

Ryan Chen Chief Executive Officer
Highly skilled serial entrepreneur and business executive
Significant experience in drug development and international marketing and product launch
William Luo Ph.D. Chief Regulatory & Clinical Officer
More than 30 years of experience in regulatory affairs and clinical trials
Beijing Honghui Institute of Pharmaceutical Research
Peng Fu Ph.D. Chief Science Officer
25 years of experience in innovative drug development and evaluation
Director of Safety Evaluation Center Tianjin
Institute of Pharmaceutical Research
Pedram Alaedini Chief Business Officer
25 years of experience in pharmaceutical manufacturing, technical services, and business development
Senior positions at Novartis, Bristol-Myers Squibb, and Schering-Plough

Ryan Chen
Chief Executive Officer
William Luo Ph.D.
Chief Regulatory & Clinical Officer
Peng Fu Ph.D.
Chief Science Officer
Pedram Alaedini
Chief Business Officer

Li Taisheng, Ph.D.,Director, Professor, Chief Physician
Director, Professor, Chief Physician, of Peking Union Medical College Hospital
Wang FushengChief Physician, and Director
Chief Physician, and Director of the National Clinical Research Center for Infectious Diseases
Xu Xiao YuanDirector
Director, Department of Infectious Diseases, Peking University Health Science Center
Wang Guiqiang, Ph.D.Director
Director of Liver Disease Center, Chief Physician, Peking University First Hospital
Duan ZhongpingChief physician, and Director
Chief physician, and Director of Beijing You'an Hospital of Capital Medical University
Tang ChengweiProfessor, doctoral supervisor
Professor, doctoral supervisor of gastroenterology, national advanced medical and health workers, and national outstanding youth.
Yang YunshengChief Physician, and Doctoral Supervisor
Chief Physician, and Doctoral Supervisor, Department of Gastroenterology, General Hospital of the Chinese People's Liberation Army
Satoshi MinamizukiChairman-designate
Chairman-designate of the Chinese Medical Association Hepatology Branch
Chen MinhuChief expert/discipline leader
Chief expert/discipline leader of the Department of Gastroenterology of the First Affiliated Hospital of Sun Yat-Sen University

Li Taisheng, Ph.D.,
Director, Professor, Chief Physician
Wang Fusheng
Chief Physician, and Director
Xu Xiao Yuan
Director
Wang Guiqiang, Ph.D.
Director
Duan Zhongping
Chief physician, and Director
Tang Chengwei
Professor, doctoral supervisor
Yang Yunsheng
Chief Physician, and Doctoral Supervisor
Satoshi Minamizuki
Chairman-designate
Chen Minhu
Chief expert/discipline leader

Junlin ZhangDirector, Research & development
Over 20 years of experience in product development with emphasis on small molecule oral solid dose products. Managed large operations in generic and innovative drug development and regulatory approval.
Zou JianhongManufacturing
Over 20 years manufacturing experience in oral solid dose and freeze-dried powder injection, 8 years QAQC. Served European multinational companies and listed enterprises.
Genyuan HouQuality
Over 30 years of experience in product and quality management, familiar with the product processes of multiple formulations such as oral solid, freeze-dried powder injection, ointments, and suppositories.
Manchun ChenRegulatory
More than 10 years of experience in product quality management and drug registration. Managed generic drug registration and clinical trials.
Jianyang LuFinance
18 years of financial management experience in pharmaceutical enterprises, including 15 years at Livzon Group, familiar with the operation API and finished product, participated in large-scale projects.
Fuhai WuSales
Over 20 years of experience in the pharmaceutical industry marketing. Served foreign companies and listed enterprises. Strong practical experience in clinical promotion.